Cambridge, UK — Horizon Discovery™ Group plc (LSE:HZD) (Horizon), the international life science company supplying research tools to organizations engaged in genomics research and the development of personalized medicines, today announced it has entered into a non-exclusive license agreement with the Broad Institute to access intellectual property related to the CRISPR/Cas9 gene editing system. Under […]
Göttingen, Germany — Western Blot is widely used in research to separate and identify proteins. In this technique a mixture of proteins is separated based on molecular weight through gel electrophoresis. The content of the gel is then transferred to a membrane producing a band for each protein. The protein of interest is then detected […]
LOUGHBOROUGH, UK –– A new highly diverse library of screening compounds is designed to maximize efficiency and productivity for researchers in early phase small molecule drug discovery. By delivering exceptionally diverse coverage of the space spanned by all possible drug-like molecules and associated characteristics, the Maybridge HitCreator library provides a greater hit probability than larger, […]
Gardner, MA.-– Today, New England Peptide, Inc. (NEP) and SISCAPA Assay Technologies, Inc. (SAT) announced a collaboration for the manufacture and sale of Stable Isotope Standard (SIS) peptides for use in SISCAPA® protein quantification assays. Under the terms of the agreement, NEP will manufacture peptide standards suitable for use with SAT’s SISCAPA assays. The peptides […]
Cambridge, UK — BioSilta Ltd, a developer of advanced microbial growth systems, today announced that it has received EUR 2.5 million from Omega Funds (London) and existing investor Inveni Capital (Helsinki). The funding will be used to support commercial expansion through direct sales and marketing teams in Europe and the USA, and the establishment of […]
MADISON, WISCONSIN — Promega Corporation launches a new assay validated for assessing the viability of cells in three-dimensional (3D) microtissue model systems. CellTiter-Glo® 3D Cell Viability Assay penetrates large 3D microtissue samples to provide more accurate determination of viable cells. The assay has been validated on a range of 3D microtissue model systems, generated using […]
San Diego, CA — The Hippo pathway is a highly conserved signaling pathway that relays signals from the cell membrane to the nucleus to negatively regulate TEAD-mediated transcription. Increased TEAD transcription can result in increased tumor growth. Alternatively, TEAD transcription leads to regenerative proliferation. Therefore, Hippo pathway activators could serve as cancer therapeutics, while Hippo […]
Schlieren, Switzerland — InSphero AG, the leading provider of 3D cell culture technology, assay-ready 3D microtissues, and 3D-focused contract research testing services, announced today the release of their new 3D InSight™ Cytotoxicity Assay Kit. The biochemical assay incorporates proprietary luminescent detection technology with improved reagent stability developed by Promega Corporation (Madison, WI) for measurement of […]
TUCSON, Ariz. -– Today HTG Molecular Diagnostics announced the availability of HTG EdgeSeq miRNA Whole Transcriptome Assay for measuring the expression of 2,275 human microRNAs (miRNAs) described in the miRBase v20 database. The assay measures expression from very small, sometimes difficult sample types such as formalin-fixed, paraffin-embedded (FFPE) tissues and plasma. Automated on the HTG […]
Cambridge, UK — Horizon Discovery™ Group plc (LSE: HZD) (“Horizon” or “the Company”), the international life science company supplying research tools to organisations engaged in genomics research and the development of personalised medicines, today announces the appointment of Dr. Susan Galbraith, Senior Vice President and Head of Oncology Innovative Medicines at AstraZeneca, and Susan Searle, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
